Should novel organisms developed using oligonucleotide-mediated mutagenesis be excluded from the EU Regulation

Last updated on 23-8-2019 by Anonymous (non vérifié)

Non-peer reviewed scientific publication




This paper discusses regulatory and safety issues associated with the use of oligonucleotide-mediated mutagenesis and provides scientific arguments for not having organisms developed through this technique fall within the scope of the EU regulation of GMOs.

Associated health topics:

QR code

QR code for this page URL